<link rel="stylesheet" href="styles.f3b1fba60ec7970c.css">

Elevated basal progesterone levels are associated with increased preovulatory progesterone rise but not with higher pregnancy rates in ICSI cycles with GnRH antagonists

dc.contributor.authorMutlu, Mehmet Firat
dc.contributor.authorErdem, Mehmet
dc.contributor.authorMutlu, Ilknur
dc.contributor.authorBulut, Berk
dc.contributor.authorErdem, Ahmet
dc.date.accessioned2026-10-09T21:47:53Z
dc.date.issued2017
dc.departmentYüksek İhtisas Üniversitesi
dc.description.abstractObjective: To ascertain the association between basal progesterone (P) levels and the occurrence of preovulatory progesterone rise (PPR) and clinical pregnancy rates (CPRs) in ICSI cycles with GnRH antagonists. Study design: Serum P levels of 464 patients were measured on day 2 and day of hCG of cycles. Cycles with basal P levels > 1.6 ng/mL were cancelled. All embryos were cryopreserved in cycles with P levels >= 2 ng/mL on the day of hCG. The primary outcome measures were the incidence of PPR (P > 1.5 ng/mL) and CPR with regard to basal P. Results: Basal P levels were significantly higher in cycles with PPR than in those without PPR (0.63 +/- 0.31 vs. 0.48 +/- 0.28 ng/mL). Area under the curve for basal P according to ROC analysis to discriminate between elevated and normal P levels on the day of hCG was 0.65 (0.58-0.71 95% CI, p < 0.01). The cut-off value for basal P levels that best discriminates between cycles with and without PPR was 0.65 ng/mL. Cycles with basal P levels above 0.65 ng/mL had a significantly higher incidence of PPR (30.9% vs. 13.5%) but similar clinical and cumulative pregnancy rates (38.8% vs. 31.1% and 41.7% vs. 32.6%, respectively) in comparison to cycles with basal P levels below 0.65 ng/mL. In multivariate regression analysis, basal P levels, LH level on the first day of antagonist administration, and estradiol levels on the day of hCG trigger were the variables that predicted PPR. Conclusion: Basal P levels were associated with increased incidence of PPR but not with CPR. (C) 2017 Elsevier B.V. All rights reserved.
dc.identifier.doi10.1016/j.ejogrb.2017.06.044
dc.identifier.endpage50
dc.identifier.issn0301-2115
dc.identifier.issn1872-7654
dc.identifier.orcid0000-0001-9944-6894
dc.identifier.pmid28715660
dc.identifier.scopus2-s2.0-85023630490
dc.identifier.scopusqualityQ2
dc.identifier.startpage46
dc.identifier.urihttps://doi.org/10.1016/j.ejogrb.2017.06.044
dc.identifier.urihttps://hdl.handle.net/20.500.12794/3508
dc.identifier.volume216
dc.identifier.wosWOS:000411771700008
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.indekslendigikaynak.digerScience Citation Index Expanded (SCI-EXPANDED)
dc.language.isoen
dc.publisherElsevier Science Bv
dc.relation.ispartofEuropean Journal of Obstetrics & Gynecology and Reproductive Biology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.relation.sdgGoal-03: Good Health and Well-Being
dc.relation.sdgGoal-05: Gender Equality
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260922
dc.subjectProgesterone
dc.subjectIntra Cytoplasmic Sperm Injection
dc.subjectGnrh Antagonists
dc.subjectPregnancy Rate
dc.titleElevated basal progesterone levels are associated with increased preovulatory progesterone rise but not with higher pregnancy rates in ICSI cycles with GnRH antagonists
dc.typeArticle

Files